Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Genetic blueprint of tumors may unlock smarter cancer care

NCT ID NCT05032092

First seen Nov 21, 2025 · Last updated May 20, 2026 · Updated 25 times

Summary

This study looks at whether a detailed genetic analysis of a patient's tumor (from a biopsy or blood sample) can help doctors pick a more effective treatment. It involves 235 adults with advanced solid cancers that have stopped responding to standard therapies. Researchers will compare how long the new, genetically-matched treatment keeps the cancer from growing versus the patient's previous therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Landesklinikum Amstetten

    Amstetten, 3300, Austria

  • Landeskrankenhaus Feldkirch, Department of Internal Medicine II

    Feldkirch, Vorarlberg, 6807, Austria

  • Medical University of Graz

    Graz, 8036, Austria

  • Medical University of Innsbruck, Department of Hematology and Oncology

    Innsbruck, Tyrol, 6020, Austria

  • Ordensklinikum Linz

    Linz, Upper Austria, 4010, Austria

  • University Hospital Salzburg, Department of Internal Medicine III

    Salzburg, State of Salzburg, 5020, Austria

Conditions

Explore the condition pages connected to this study.